Format

Send to

Choose Destination
Brain. 2017 Apr 1;140(4):1158-1165. doi: 10.1093/brain/awx022.

Operationalizing compensation over time in neurodegenerative disease.

Author information

1
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
2
Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa, City, IA, USA.
3
Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
4
Albert-Ludwigs-University Freiburg, University Medical Center, Division Freiburg Brain Imaging, Freiburg, Germany.
5
Albert-Ludwigs-University Freiburg, University Medical Center, Department of Psychiatry and Psychotherapy, Freiburg, Germany.
6
University Hospital for Old Age Psychiatry, Murtenstrasse 21, 3010 Bern, Switzerland.
7
Department of Electronic Engineering, N.E.D University of Engineering and Technology, Karachi, Pakistan.
8
Albert-Ludwigs-University Freiburg, Department of Psychology, Laboratory for Biological and Personality Psychology, Freiburg, Germany.
9
Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK.
10
APHP Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière, and Institut du Cerveau et de la Moelle, INSERM U1127, CNRS UMR7225, UPMC Université Paris VI UMR_S1127, Paris France.
11
Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Canada.
12
Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands.
13
School of Psychological Sciences and Institute of Clinical and Cognitive Neuroscience, Monash University, Melbourne, Australia.
14
Institute of Cognitive Neuroscience, University College London, London, UK.

KEYWORDS:

Huntington’s disease; MRI; compensation; longitudinal analysis; neurodegeneration

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center